 | • レポートコード：QFJ1-4588 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、非ホジキンリンパ腫＆慢性リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（B細胞、T細胞）、用途別市場規模（化学療法、免疫療法、標的療法、放射線療法、幹細胞移植）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・非ホジキンリンパ腫＆慢性リンパ腫治療の市場動向 ・企業の競争状況、市場シェア ・非ホジキンリンパ腫＆慢性リンパ腫治療の種類別市場規模と予測2016-2027（B細胞、T細胞） ・非ホジキンリンパ腫＆慢性リンパ腫治療の用途別市場規模と予測2016-2027（化学療法、免疫療法、標的療法、放射線療法、幹細胞移植） ・非ホジキンリンパ腫＆慢性リンパ腫治療の北米市場規模2016-2027（アメリカ、カナダ） ・非ホジキンリンパ腫＆慢性リンパ腫治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・非ホジキンリンパ腫＆慢性リンパ腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・非ホジキンリンパ腫＆慢性リンパ腫治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・非ホジキンリンパ腫＆慢性リンパ腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（F. Hoffmann La-Roche Ltd.、Johnson & Johnson、Bayer AG、Eli Lilly and Company、Amgen, Inc.、Novartis AG、Gilead、Kite Pharma, Inc.、GlaxoSmithKline Plc、Bristol-Myers Squibb） ・結論 |
Non-Hodgkins Lymphoma also known as NHL is a heterogeneous and complex group of disorders that are characterized by clonal proliferation of lymphocytes at multiple stages of maturation. There are approximately 30 types of NHLs with varying pathological, clinical, and genetic features. Chronic Lymphoma (CLL) is a neoplasm of monomorphic small, round lymphocytes of B cell origin in 98% of the cases.
Market Analysis and Insights: Global Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market
The global Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment market.
Global Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Scope and Market Size
Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
B-Cell
T-Cell
Segment by Application
Chemotherapy
Immunotherapy
Targeted Therapy
Radiation Therapy
Stem Cell Transplant
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
F. Hoffmann La-Roche Ltd.
Johnson & Johnson
Bayer AG
Eli Lilly and Company
Amgen, Inc.
Novartis AG
Gilead
Kite Pharma, Inc.
GlaxoSmithKline Plc
Bristol-Myers Squibb
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 B-Cell
1.2.3 T-Cell
1.3 Market by Application
1.3.1 Global Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Chemotherapy
1.3.3 Immunotherapy
1.3.4 Targeted Therapy
1.3.5 Radiation Therapy
1.3.6 Stem Cell Transplant
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Perspective (2016-2027)
2.2 Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Growth Trends by Regions
2.2.1 Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Industry Dynamic
2.3.1 Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Trends
2.3.2 Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Drivers
2.3.3 Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Challenges
2.3.4 Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Players by Revenue
3.1.1 Global Top Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Revenue
3.4 Global Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Concentration Ratio
3.4.1 Global Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Revenue in 2020
3.5 Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Key Players Head office and Area Served
3.6 Key Players Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Product Solution and Service
3.7 Date of Enter into Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Breakdown Data by Type
4.1 Global Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Forecasted Market Size by Type (2022-2027)
5 Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Breakdown Data by Application
5.1 Global Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size (2016-2027)
6.2 North America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Type
6.2.1 North America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2016-2027)
6.3 North America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Application
6.3.1 North America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2016-2027)
6.4 North America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Country
6.4.1 North America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size (2016-2027)
7.2 Europe Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Type
7.2.1 Europe Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2016-2027)
7.3 Europe Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Application
7.3.1 Europe Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2016-2027)
7.4 Europe Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Country
7.4.1 Europe Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Type
8.2.1 Asia-Pacific Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Application
8.3.1 Asia-Pacific Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Region
8.4.1 Asia-Pacific Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size (2016-2027)
9.2 Latin America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Type
9.2.1 Latin America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Application
9.3.1 Latin America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Country
9.4.1 Latin America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Type
10.2.1 Middle East & Africa Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Application
10.3.1 Middle East & Africa Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Country
10.4.1 Middle East & Africa Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 F. Hoffmann La-Roche Ltd.
11.1.1 F. Hoffmann La-Roche Ltd. Company Details
11.1.2 F. Hoffmann La-Roche Ltd. Business Overview
11.1.3 F. Hoffmann La-Roche Ltd. Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Introduction
11.1.4 F. Hoffmann La-Roche Ltd. Revenue in Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Business (2016-2021)
11.1.5 F. Hoffmann La-Roche Ltd. Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Introduction
11.2.4 Johnson & Johnson Revenue in Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Bayer AG
11.3.1 Bayer AG Company Details
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Introduction
11.3.4 Bayer AG Revenue in Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Business (2016-2021)
11.3.5 Bayer AG Recent Development
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Details
11.4.2 Eli Lilly and Company Business Overview
11.4.3 Eli Lilly and Company Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Introduction
11.4.4 Eli Lilly and Company Revenue in Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Business (2016-2021)
11.4.5 Eli Lilly and Company Recent Development
11.5 Amgen, Inc.
11.5.1 Amgen, Inc. Company Details
11.5.2 Amgen, Inc. Business Overview
11.5.3 Amgen, Inc. Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Introduction
11.5.4 Amgen, Inc. Revenue in Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Business (2016-2021)
11.5.5 Amgen, Inc. Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Details
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Introduction
11.6.4 Novartis AG Revenue in Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Business (2016-2021)
11.6.5 Novartis AG Recent Development
11.7 Gilead
11.7.1 Gilead Company Details
11.7.2 Gilead Business Overview
11.7.3 Gilead Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Introduction
11.7.4 Gilead Revenue in Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Business (2016-2021)
11.7.5 Gilead Recent Development
11.8 Kite Pharma, Inc.
11.8.1 Kite Pharma, Inc. Company Details
11.8.2 Kite Pharma, Inc. Business Overview
11.8.3 Kite Pharma, Inc. Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Introduction
11.8.4 Kite Pharma, Inc. Revenue in Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Business (2016-2021)
11.8.5 Kite Pharma, Inc. Recent Development
11.9 GlaxoSmithKline Plc
11.9.1 GlaxoSmithKline Plc Company Details
11.9.2 GlaxoSmithKline Plc Business Overview
11.9.3 GlaxoSmithKline Plc Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Introduction
11.9.4 GlaxoSmithKline Plc Revenue in Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Business (2016-2021)
11.9.5 GlaxoSmithKline Plc Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Details
11.10.2 Bristol-Myers Squibb Business Overview
11.10.3 Bristol-Myers Squibb Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Introduction
11.10.4 Bristol-Myers Squibb Revenue in Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Business (2016-2021)
11.10.5 Bristol-Myers Squibb Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of B-Cell
Table 3. Key Players of T-Cell
Table 4. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Regions (2016-2021)
Table 8. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Regions (2022-2027)
Table 10. Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Trends
Table 11. Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Drivers
Table 12. Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Challenges
Table 13. Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Restraints
Table 14. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Players (2016-2021)
Table 16. Global Top Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment as of 2020)
Table 17. Ranking of Global Top Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Product Solution and Service
Table 21. Date of Enter into Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. F. Hoffmann La-Roche Ltd. Company Details
Table 62. F. Hoffmann La-Roche Ltd. Business Overview
Table 63. F. Hoffmann La-Roche Ltd. Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Product
Table 64. F. Hoffmann La-Roche Ltd. Revenue in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 65. F. Hoffmann La-Roche Ltd. Recent Development
Table 66. Johnson & Johnson Company Details
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Product
Table 69. Johnson & Johnson Revenue in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 70. Johnson & Johnson Recent Development
Table 71. Bayer AG Company Details
Table 72. Bayer AG Business Overview
Table 73. Bayer AG Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Product
Table 74. Bayer AG Revenue in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 75. Bayer AG Recent Development
Table 76. Eli Lilly and Company Company Details
Table 77. Eli Lilly and Company Business Overview
Table 78. Eli Lilly and Company Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Product
Table 79. Eli Lilly and Company Revenue in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 80. Eli Lilly and Company Recent Development
Table 81. Amgen, Inc. Company Details
Table 82. Amgen, Inc. Business Overview
Table 83. Amgen, Inc. Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Product
Table 84. Amgen, Inc. Revenue in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 85. Amgen, Inc. Recent Development
Table 86. Novartis AG Company Details
Table 87. Novartis AG Business Overview
Table 88. Novartis AG Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Product
Table 89. Novartis AG Revenue in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 90. Novartis AG Recent Development
Table 91. Gilead Company Details
Table 92. Gilead Business Overview
Table 93. Gilead Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Product
Table 94. Gilead Revenue in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 95. Gilead Recent Development
Table 96. Kite Pharma, Inc. Company Details
Table 97. Kite Pharma, Inc. Business Overview
Table 98. Kite Pharma, Inc. Revenue in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 99. Kite Pharma, Inc. Recent Development
Table 100. GlaxoSmithKline Plc Company Details
Table 101. GlaxoSmithKline Plc Business Overview
Table 102. GlaxoSmithKline Plc Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Product
Table 103. GlaxoSmithKline Plc Revenue in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 104. GlaxoSmithKline Plc Recent Development
Table 105. Bristol-Myers Squibb Company Details
Table 106. Bristol-Myers Squibb Business Overview
Table 107. Bristol-Myers Squibb Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Product
Table 108. Bristol-Myers Squibb Revenue in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 109. Bristol-Myers Squibb Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. B-Cell Features
Figure 3. T-Cell Features
Figure 4. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Application: 2020 VS 2027
Figure 5. Chemotherapy Case Studies
Figure 6. Immunotherapy Case Studies
Figure 7. Targeted Therapy Case Studies
Figure 8. Radiation Therapy Case Studies
Figure 9. Stem Cell Transplant Case Studies
Figure 10. Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Report Years Considered
Figure 11. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Regions (2022-2027)
Figure 15. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Players in 2020
Figure 16. Global Top Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Revenue in 2020
Figure 18. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Type (2016-2027)
Figure 22. North America Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Application (2016-2027)
Figure 23. North America Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Country (2016-2027)
Figure 24. United States Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Type (2016-2027)
Figure 28. Europe Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Application (2016-2027)
Figure 29. Europe Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Country (2016-2027)
Figure 30. Germany Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Region (2016-2027)
Figure 40. China Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. F. Hoffmann La-Roche Ltd. Revenue Growth Rate in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Business (2016-2021)
Figure 61. Bayer AG Revenue Growth Rate in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Business (2016-2021)
Figure 62. Eli Lilly and Company Revenue Growth Rate in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Business (2016-2021)
Figure 63. Amgen, Inc. Revenue Growth Rate in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Business (2016-2021)
Figure 64. Novartis AG Revenue Growth Rate in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Business (2016-2021)
Figure 65. Gilead Revenue Growth Rate in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Business (2016-2021)
Figure 66. Kite Pharma, Inc. Revenue Growth Rate in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Business (2016-2021)
Figure 67. GlaxoSmithKline Plc Revenue Growth Rate in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Business (2016-2021)
Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界のB細胞非ホジキンリンパ腫（NHL）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market The global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy…- 世界の皮膚B細胞リンパ腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous B-Cell Lymphoma Treatment Market The global Cutaneous B-Cell Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and hig…
- 世界の非ホジキンリンパ腫治療市場規模・現状・予測（2021年-2027年） Non-Hodgkin’s lymphomas are one of the most commonly occurring cases of lymphomas and hence is also one of the most commonly occurring cancers. If not treated effectively, it is potentially lethal and leads to a shorter life span of the individuals diagnosed. Market Analysis and Insights: Global Non…
- 世界の末梢T細胞リンパ腫（PTCL）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market The global Peripheral T-Cell Lymphoma (PTCL) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
- 世界の皮膚T細胞リンパ腫（CTCL）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous T-Cell Lymphoma (CTCL) Treatment Market The global Cutaneous T-Cell Lymphoma (CTCL) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in an…